CN1714091A - 中位取代卟啉 - Google Patents

中位取代卟啉 Download PDF

Info

Publication number
CN1714091A
CN1714091A CNA2003801017372A CN200380101737A CN1714091A CN 1714091 A CN1714091 A CN 1714091A CN A2003801017372 A CNA2003801017372 A CN A2003801017372A CN 200380101737 A CN200380101737 A CN 200380101737A CN 1714091 A CN1714091 A CN 1714091A
Authority
CN
China
Prior art keywords
phenyl
porphyrin
oxygen
group
last
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2003801017372A
Other languages
English (en)
Chinese (zh)
Inventor
加布里奥·龙库奇
多娜塔·代
弗兰切斯卡·琼蒂尼
贾科莫·基蒂
达尼埃莱·尼斯特里
莉娅·凡泰蒂
瓦伦丁娜·帕斯凯塔
安纳利萨·科基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc
Original Assignee
DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32104761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1714091(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc filed Critical DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc
Publication of CN1714091A publication Critical patent/CN1714091A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2003801017372A 2002-10-21 2003-10-21 中位取代卟啉 Pending CN1714091A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI2002A000200 2002-10-21
IT000200A ITFI20020200A1 (it) 2002-10-21 2002-10-21 Porfirine meso-sostituite.

Publications (1)

Publication Number Publication Date
CN1714091A true CN1714091A (zh) 2005-12-28

Family

ID=32104761

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2003801017372A Pending CN1714091A (zh) 2002-10-21 2003-10-21 中位取代卟啉

Country Status (17)

Country Link
US (2) US7947674B2 (enExample)
EP (1) EP1558616B2 (enExample)
JP (1) JP4751068B2 (enExample)
CN (1) CN1714091A (enExample)
AT (1) ATE387450T1 (enExample)
AU (1) AU2003278118B8 (enExample)
CA (1) CA2503223C (enExample)
CY (1) CY1107963T1 (enExample)
DE (1) DE60319406T3 (enExample)
DK (1) DK1558616T4 (enExample)
ES (1) ES2301840T5 (enExample)
IL (1) IL168104A0 (enExample)
IT (1) ITFI20020200A1 (enExample)
PT (1) PT1558616E (enExample)
SI (1) SI1558616T2 (enExample)
WO (1) WO2004035590A2 (enExample)
ZA (1) ZA200504102B (enExample)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102159569A (zh) * 2008-09-18 2011-08-17 塞拉莫普泰克工业公司 用于pdt的不对称内消旋取代的卟啉和二氢卟酚的新方法及其应用
CN102180881A (zh) * 2011-03-25 2011-09-14 西北农林科技大学 3,8,13-三碘-5,10,15-三烷基三聚吲哚的制备方法
CN102499924A (zh) * 2011-11-23 2012-06-20 中国医学科学院生物医学工程研究所 二乙撑三胺五乙酸或乙二胺四乙酸或胺三乙酸修饰卟啉的用途
CN104725388A (zh) * 2015-03-25 2015-06-24 南京林业大学 一种meso位芳胺基单取代卟啉衍生物及其制备方法
CN105924448A (zh) * 2016-06-27 2016-09-07 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN105949208A (zh) * 2016-06-27 2016-09-21 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Zn配合物的合成方法
CN106046010A (zh) * 2016-06-27 2016-10-26 桂林理工大学 5‑对苯甲酸基‑10, 15, 20‑三对异辛烷氧基苯基卟啉的合成方法
CN106047369A (zh) * 2016-06-27 2016-10-26 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117227A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117222A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料合成方法
CN106118688A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117228A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117221A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117224A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117225A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106117223A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117220A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106118689A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106146523A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106146522A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106588941A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲十二烷氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588942A (zh) * 2016-12-08 2017-04-26 桂林理工大学 并菲癸氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588940A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲癸氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749285A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲己氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749284A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106905334A (zh) * 2017-04-22 2017-06-30 桂林理工大学 苯并菲十二烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN106967075A (zh) * 2017-04-22 2017-07-21 桂林理工大学 苯并菲癸烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107011349A (zh) * 2017-04-22 2017-08-04 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN107043381A (zh) * 2017-04-22 2017-08-15 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN107089987A (zh) * 2017-04-22 2017-08-25 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN110354770A (zh) * 2019-07-23 2019-10-22 中国石油大学(华东) 一种人工光合微反应器及制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356813B1 (en) * 2002-04-25 2005-07-20 L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI Antibacterial compositions comprising metal phthalocyanine analogues
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CA2528347A1 (en) * 2003-06-06 2005-01-06 Eukarion, Inc. Orally bioavailable low molecular weight metalloporphyrins as antioxidants
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB2415373A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Porphyrins for sonodynamic therapy
GB0526474D0 (en) * 2005-12-24 2006-02-08 Destiny Pharma Ltd Novel process
WO2008108937A1 (en) 2007-03-05 2008-09-12 North Carolina State University Method of making porphyrins
EP2759546B1 (en) * 2011-09-21 2018-03-21 National University Corporation Okayama University Metalloporphyrin complex, manufacturing process therefor and its use as carbon dioxide fixation catalyst, as well as process for manufacturing cyclic carbonate
US9364537B2 (en) * 2014-08-22 2016-06-14 University Of Dayton Transition metal porphyrin complexes and methods of treatment using same
KR20180100570A (ko) * 2016-01-13 2018-09-11 제이에스알 가부시끼가이샤 감방사선성 수지 조성물, 레지스트 패턴 형성 방법, 산 확산 제어제 및 화합물
US10722582B2 (en) * 2018-04-12 2020-07-28 Purdue Research Foundation Targeted antimicrobial photodynamic therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
IL122451A0 (en) * 1995-06-07 1998-06-15 Univ Duke Oxidant scavengers
WO1998033503A1 (en) * 1997-02-05 1998-08-06 Board Of Regents, The University Of Texas System Porphyrin compounds as telomerase inhibitors
IT1294325B1 (it) 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
CA2341507C (en) * 1998-08-28 2011-05-24 William Guy Love Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
ATE259814T1 (de) * 2000-06-15 2004-03-15 Molteni & C Substituierte metallphthalocyaninen, ihre herstellung und verwendung
FR2812637B1 (fr) * 2000-08-01 2002-10-25 Anulm Ass Nantaise Pour L Util Nouveaux composes derives de dihydroporphyrine et leurs applications
CA2441386C (en) 2001-03-21 2010-12-21 L. Molteni E C. Dei Fratelli Alitti Societa Di Esercizio S.P.A. Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
ITFI20020200A1 (it) 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102159569A (zh) * 2008-09-18 2011-08-17 塞拉莫普泰克工业公司 用于pdt的不对称内消旋取代的卟啉和二氢卟酚的新方法及其应用
CN102159569B (zh) * 2008-09-18 2016-02-03 拜莱泰克制药市场有限公司 用于pdt的不对称内消旋取代的卟啉和二氢卟酚及其应用
CN102180881A (zh) * 2011-03-25 2011-09-14 西北农林科技大学 3,8,13-三碘-5,10,15-三烷基三聚吲哚的制备方法
CN102499924A (zh) * 2011-11-23 2012-06-20 中国医学科学院生物医学工程研究所 二乙撑三胺五乙酸或乙二胺四乙酸或胺三乙酸修饰卟啉的用途
CN104725388A (zh) * 2015-03-25 2015-06-24 南京林业大学 一种meso位芳胺基单取代卟啉衍生物及其制备方法
CN104725388B (zh) * 2015-03-25 2017-03-15 南京林业大学 一种meso位芳胺基单取代卟啉衍生物及其制备方法
CN106117223A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106146523A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106047369A (zh) * 2016-06-27 2016-10-26 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117227A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117222A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料合成方法
CN106118688A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117228A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117221A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117224A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117225A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN105949208A (zh) * 2016-06-27 2016-09-21 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Zn配合物的合成方法
CN106117220A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106118689A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106046010A (zh) * 2016-06-27 2016-10-26 桂林理工大学 5‑对苯甲酸基‑10, 15, 20‑三对异辛烷氧基苯基卟啉的合成方法
CN106146522A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN105924448A (zh) * 2016-06-27 2016-09-07 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106588941A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲十二烷氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588942A (zh) * 2016-12-08 2017-04-26 桂林理工大学 并菲癸氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588940A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲癸氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749285A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲己氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749284A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106905334A (zh) * 2017-04-22 2017-06-30 桂林理工大学 苯并菲十二烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN106967075A (zh) * 2017-04-22 2017-07-21 桂林理工大学 苯并菲癸烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107011349A (zh) * 2017-04-22 2017-08-04 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN107043381A (zh) * 2017-04-22 2017-08-15 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN107089987A (zh) * 2017-04-22 2017-08-25 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN110354770A (zh) * 2019-07-23 2019-10-22 中国石油大学(华东) 一种人工光合微反应器及制备方法

Also Published As

Publication number Publication date
ES2301840T3 (es) 2008-07-01
CA2503223C (en) 2010-11-23
EP1558616B2 (en) 2011-08-24
US8288528B2 (en) 2012-10-16
CA2503223A1 (en) 2004-04-29
IL168104A0 (en) 2009-02-11
DE60319406T3 (de) 2012-02-23
IT1333697B (enExample) 2006-05-09
EP1558616A2 (en) 2005-08-03
ZA200504102B (en) 2006-07-26
AU2003278118A1 (en) 2004-05-04
DK1558616T3 (da) 2008-06-23
US7947674B2 (en) 2011-05-24
WO2004035590A3 (en) 2004-07-29
PT1558616E (pt) 2008-05-12
JP2006512301A (ja) 2006-04-13
US20060040914A1 (en) 2006-02-23
AU2003278118B8 (en) 2009-09-17
ITFI20020200A1 (it) 2004-04-22
SI1558616T1 (sl) 2008-08-31
WO2004035590A2 (en) 2004-04-29
CY1107963T1 (el) 2013-09-04
AU2003278118B2 (en) 2009-05-21
US20110112464A1 (en) 2011-05-12
EP1558616B1 (en) 2008-02-27
JP4751068B2 (ja) 2011-08-17
DK1558616T4 (da) 2011-12-12
ES2301840T5 (es) 2012-01-13
DE60319406T2 (de) 2009-03-19
ATE387450T1 (de) 2008-03-15
DE60319406D1 (de) 2008-04-10
SI1558616T2 (sl) 2011-12-30

Similar Documents

Publication Publication Date Title
CN1714091A (zh) 中位取代卟啉
CN1310907C (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1124279C (zh) 铂配合物、其制备和治疗应用
CN1310906C (zh) 用作p38激酶抑制剂的吲哚类型的衍生物
CN1160069C (zh) 钯取代的细菌叶绿素衍生物及其应用
CN1560035A (zh) 5－羟基吲哚－3－羧酸脂类衍生物
CN1933834A (zh) 吲唑甲酰胺衍生物在制备用于治疗和预防疟疾的药物中的用途
CN1271355A (zh) 杂环化合物和以其为有效成分的抗肿瘤剂
CN1659166A (zh) 作为5－羟色胺－6配体的1－(氨基烷基)－3－磺酰基氮杂吲哚
CN1668590A (zh) 用作5－羟色胺－6配体的1－杂环基烷基－3－磺酰基－吲哚或－吲唑衍生物
CN1656082A (zh) 蛋白激酶抑制剂
CN1425015A (zh) 叶绿素和细菌叶绿素酯、它们的制备及含有它们的药用组合物
CN1771244A (zh) 作为5－羟色胺－6配体的杂环－3－磺酰基吲唑
CN1320123A (zh) 二取代马来酰亚胺化合物及其医药用途
CN87103504A (zh) 杂环羧酰胺
CN1191049C (zh) 阳离子单苯基硝基苯二胺类化合物及其在染色角质纤维中的用途，含该物质的染色组合物及染色方法
CN1100414A (zh) 含有新型喹啉衍生物的药用复合物的制备方法
CN1244577C (zh) 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物
CN1232518C (zh) 具有抗肿瘤和化学敏感活性的双杂环化合物
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1807413A (zh) 咔唑磺酰胺衍生物及其制备方法
CN1067072C (zh) 三环化合物、它们的制备及其用途
CN1402724A (zh) 作为抗糖尿病剂的新的噻唑烷二酮衍生物
CN1191241C (zh) 用于抗充血性心力衰竭的哒嗪基苯基腙
CN1049156A (zh) 茚并吲哚化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20051228